In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Acino International AG

https://acino.swiss.com

Latest From Acino International AG

Aspen Offloads Six In South Africa With Debt Still A Priority

South Africa’s Aspen Pharmacare is continuing along the path of offloading assets that no longer fit into its strategy, using the proceeds to pay off its substantial debt pile and reinvest in areas of greater strategic focus. Half-a-dozen products currently offered in its local market are now on their way to Switzerland’s Acino.

M & A Deals

Celltrion Strikes $278m Deal With Takeda

Celltrion has bought a portfolio of selected products in the Asia-Pacific region from Takeda, marking a foray into small-molecule drugs.

Deals Strategy

Celltrion Expands In APAC, Small Molecules Via $278m Takeda Asset Buy

In continuing strategy to shed non-core assets globally, Japanese firm will sell portfolio of selected products in Asia-Pacific to Korean biosimilars giant Celltrion.

Asia Pacific Business Strategies

Takeda Sheds More Non-Core Assets, Employees In $670m Orifarm Deal

Danish firm picks up portfolio and manufacturing sites, along with around 600 employees.

Business Strategies Commercial
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
    • Drug Delivery
      • Controlled Release
  • Other Names / Subsidiaries
    • Acino Holding AG
UsernamePublicRestriction

Register